ArticlesArchiveAboutEditorial BoardAuthor Guidelines
Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En…
Peter Chin Wan Fung, Regina Kit Chee Kong
Heat shock proteins (HSPs) serve to correct proteins’ conformation, send the damaged proteins for degradation (quality control function). Heat shock factors (HSFs) are their transcription factors. The protein complexes mTOR1 and 2 (with the same core mTOR), t…
Daadoucha Abderrahmen, Farhat Waad, Ben Mabrouk Mohamed, Harrabi Fathia, Azzaza Mohamed, Ben Ali Ali
Gastrointestinal stromal tumours (GIST) are rare mesenchymal neoplasms that can develop in the entire length of the gastrointestinal tract or sometimes from the omentum and mesentery. In most cases, they arise from the stom ach, less often the jejunum or ileu…
Lamiae Amaadour, Zineb Benbrahim, Nadia Benaicha, Fatima Zahra Elmrabet, Samia Arifi, Chakib Nejjari, Nawfel Mellas
Background: Tumor-related leukocytosis is a paraneoplastic syndrome that is encountered occasionally in the clinical course of patients with lung carcinoma. The aim of this study is to evaluate the prognostic significance of leucocytosis in patients with meta…
Rafael Cholvi Calduch, Raquel Alfonso-Ballester, Clara Alfaro-Cervelló, Norberto Cassinello Fernández, Joaquín Ortega Serrano
Clear cell type renal cell carcinoma is a malignant tumor that can metastasize to many locations, but unusually spreads to thyroid. Therefore it is important to know the oncological background of the patient and to perform a complete immunohistochemical analy…
Maria Rosaria Valerio, Chiara Ancona, Antonella Marchese, Vittorio Gebbia
Background : Agent targeting HER-2 pathway plus chemotherapy has represented a major progress in the management of patients with breast cancer. However , the role of late-line treatment in heavily pretreated patients is still largely unclear. In the last deca…
Lydie Estelle Djanhan, Jean Marc Dia, Boston Mian, Mouhideen Oyelade, Aboulaye Diallo, Privat Guié, Simplice Anongba
Objective: Describe the occurrence delays of metastatic relapses of breast cancer based on the characteristics of the original tumor. Methodology : This is a retrospective and cohort study conducted from January 2000 to December 2015 on patients with metastat…
Amanda M. Farr, Zhongyun Zhao, Xue Song, Beth Barber, Boris Ivanov, Marilyn Novich
Background: Melanoma is a rare but serious skin cancer that is responsible for >90% of skin cancer-related deaths. This retrospective data analysis quantifies the direct cost of medical care by disease stage at diagnosis for patients with metastatic melanoma.…
Evgeniy I. Volkov, Andrei V. Reshetnickov, Harrie Vink
Bremachlorin ® , also known as “Radachlorin ® ” and Photochlorin, a composition of 3 chlorophyll a derivatives in an aqueous solution [1] , was initially introduced into the Russian and South Korean Pharmacopoeias with the corresponding marketing author…
Mohamed Mahmoud, Mahmoud Shosha, Maha Hassan, Shaimaa Abdelgelil, Sandy Mohamed
Purpose : To test the use of Intensity Modulated Radiotherapy (IMRT) to spare the bone marrow (BM) in patients treated with cancer cervix through using the bone marrow an organ at risk. Patients and methods : Thirteen patients with stage (IB2-IIIB) intact cer…
Mary M. Flynn, Jennifer Cunningham, Joseph Renzulli, Anthony Mega
Recommendations for prostate cancer treatment include weight loss, but the most efficacious diet has not been determined. Men on active surveillance or with untreated biochemical relapse consumed both the diet recommended by the Prostate Cancer Foundation (PC…
No articles in this issue.
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).